Keel Pharmaceuticals
Keel Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat type 1 diabetes and other autoimmune diseases.
Keel Pharmaceuticals is a business in biotechnology, health care, pharmaceutical based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2002.
The company sits in the biotechnology, health care, pharmaceutical segment, where it competes on its core product or service.
Its base of operations is Greater Boston Area, East Coast, New England, Northeastern US.
Its current recorded stage is Private company.
| Sector | Biotechnology, Health Care, Pharmaceutical |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Founded | 2002 |
| Stage | Private company |
Website: keelpharmaceuticals.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account